AzTrials
AzTrials

Direct Pulp CappingPhase 3NCT05530954

Direct Pulp Capping in Primary Molars

A Phase 3 study testing Mineral trioxide aggregate (MTA) and Hard setting Calcium Hydroxide (Dycal) in people with Direct Pulp Capping, run by Mansoura University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to Assess the effect of MTA and hard setting Calcium Hydroxide (Dycal) on the clinical and radiographic outcome of direct pulp capping in primary molars and evaluate overall success rate of direct pulp capping in primary molars. Read more about this study

Who is it for?
Ages 4 to 7 yearsHealthy volunteers can take part
Conditions the study is for
Direct Pulp Capping
What is being tested?
Mineral trioxide aggregate (MTA) and Hard setting Calcium Hydroxide (Dycal)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
52 participants
Where
1 siteEgypt
Study dates
1 Jan 2022to 6 Jun 2023
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 7 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Cooperative child and compliant parent.
  • Complete physical and mental health.
  • Children who are known to be healthy and free from systemic diseases.
  • Primary molars with deep carious lesions leading to pathological exposure but with no signs or symptoms of irreversible pulpitis or necrosis such as spontaneous pain, tenderness to percussion, abscess, fistula, periodontal tissue swelling, or abnormal tooth mobility.

Who cannot join

  • A deep carious lesion in close proximity to the pulp with an intact lamina dura.
  • Absence of widening of periodontal membrane space or radiolucency at the furcation and periapical region.
  • Absence of pulpal calcifications, obliteration of the pulp and root canal, or internal/external root resorption.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Outpatient clinic of the Department of Pediatric Dentistry, Faculty of Dentistry- Mansoura University

    Al Mansurah

Other trials in Egypt

About this study

Official title: Clinical Evaluation of Direct Pulp Capping in Primary Molars

The purpose of this study is to Assess the effect of MTA and hard setting Calcium Hydroxide (Dycal) on the clinical and radiographic outcome of direct pulp capping in primary molars and evaluate overall success rate of direct pulp capping in primary molars.

Read the detailed description

After informed consent, baseline clinical and radiographic assessment will be obtained and recorded in patient examination sheet.

Participants who met the inclusion criteria were randomly allocated to two groups (n = 26/group, N = 52 in total) according to the capping martials using the envelope randomization method.

2 study groups according to capping material that will be used (Dycal or MTA) and each group will be divided to 2 subgroups according to site of exposure axial or pulpal.

All patients were recalled and their treated molars were evaluated clinically and radiographically at 3months, 6months, 9months ,12months follow up periods.

Being tested
Mineral trioxide aggregate (MTA), Hard setting Calcium Hydroxide (Dycal)
Keywords
primary dentition, MTA, Dycal, bioactive material, deciduous dentition, Direct pulp capping

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mineral trioxide aggregate (MTA)Other

    Also called BIO MTA, CERKAMED, Poland

    Materials for Vital Pulp Capping

  • Hard setting Calcium Hydroxide (Dycal)Other

    Also called Dycal, Promedica Urbical, Germany

    Materials for Vital Pulp Capping

Study groups in NCT05530954
Study groupRoleWhat they receive
Mineral trioxide aggregate (MTA)Active comparator* where the pulp tissue is exposed during final caries removal, hemostasis will be achieved by cavity irrigation with sterile saline solution for up to 4 minutes till control of bleeding * Teeth with pulp exposure less than 1mm in diameter surrounded by sound dentin will be candidates for direct pulp capping * Following the removal of the saline, the exposed pulp will be irrigated with 17% EDTA solution (Prevest Direct, India) for 1 minute * According to site of exposure, the groups will be further subdivided into Group A (n=13) with exposure in pulpal floor and Group B (n=13) with exposure in axial wall of the cavity. * Exposed pulp will be covered with fast set MTA paste after cavity dryness with sterile cotton pellet then the tooth will be restored with Self-cured glass ionomer restorative material (SDI Riva self-cure, Australia) and tooth will be covered by stainless steel crown
Receives: Other: Mineral trioxide aggregate (MTA)
Hard setting Calcium Hydroxide (Dycal)Active comparator* where the pulp tissue is exposed during final caries removal, hemostasis will be achieved by cavity irrigation with sterile saline solution for up to 4 minutes till control of bleeding * Teeth with pulp exposure less than 1mm in diameter surrounded by sound dentin will be candidates for direct pulp capping * Following the removal of the saline, the exposed pulp will be irrigated with 17% EDTA solution (Prevest Direct, India) for 1 minute * According to site of exposure, the groups will be further subdivided into Group A (n=13) with exposure in pulpal floor and Group B (n=13) with exposure in axial wall of the cavity. * Exposed pulp will be covered with Dycal paste after cavity dryness with sterile cotton pellet then the tooth will be restored with Self-cured glass ionomer restorative material (SDI Riva self-cure, Australia) and tooth will be covered by stainless steel crown
Receives: Other: Hard setting Calcium Hydroxide (Dycal)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. clinical success of direct pulp capping treatment after 3 months follow up

    Presence of any of these clinical findings will be considered failure:

    pain on mastication or spontaneous pain, as reported by the patient, without clinical evidence of plaque retention around the crown margin denoting bad oral hygiene.

    pain on percussion on clinical examination . non-physiologic mobility. fistula or sinus tract.

    Measured: 3 months

  2. clinical success of direct pulp capping treatment after 6 months follow up

    Presence of any of these clinical findings will be considered failure:

    pain on mastication or spontaneous pain, as reported by the patient, without clinical evidence of plaque retention around the crown margin denoting bad oral hygiene.

    pain on percussion on clinical examination . non-physiologic mobility. fistula or sinus tract.

    Measured: 6 months follow up

  3. clinical success of direct pulp capping treatment after 9 months follow up

    Presence of any of these clinical findings will be considered failure:

    pain on mastication or spontaneous pain, as reported by the patient, without clinical evidence of plaque retention around the crown margin denoting bad oral hygiene.

    pain on percussion on clinical examination . non-physiologic mobility. fistula or sinus tract.

    Measured: 9 months follow up

  4. clinical success of direct pulp capping treatment after 12 months follow up

    Presence of any of these clinical findings will be considered failure:

    pain on mastication or spontaneous pain, as reported by the patient, without clinical evidence of plaque retention around the crown margin denoting bad oral hygiene.

    pain on percussion on clinical examination . non-physiologic mobility. fistula or sinus tract.

    Measured: 12 months follow up

  5. radiographic success of direct pulp capping treatment after 3 months follow up

    the absence of the following radiographic findings indicate the success of capping material in pulp therapy:

    • pathological internal or external root resorption.
    • PDL widening.
    • inter-radicular radiolucency formation postoperatively.
    • periapical radiolucency formation postoperatively.

    Measured: 3 months follow up

  6. radiographic success of direct pulp capping treatment after 6 months follow up

    the absence of the following radiographic findings indicate the success of capping material in pulp therapy:

    • pathological internal or external root resorption.
    • PDL widening.
    • inter-radicular radiolucency formation postoperatively.
    • periapical radiolucency formation postoperatively.

    Measured: 6 months follow up

  7. radiographic success of direct pulp capping treatment after 9 months follow up

    the absence of the following radiographic findings indicate the success of capping material in pulp therapy:

    • pathological internal or external root resorption.
    • PDL widening.
    • inter-radicular radiolucency formation postoperatively.
    • periapical radiolucency formation postoperatively.

    Measured: 9 months follow up

  8. radiographic success of direct pulp capping treatment after 12 months follow up

    the absence of the following radiographic findings indicate the success of capping material in pulp therapy:

    • pathological internal or external root resorption.
    • PDL widening.
    • inter-radicular radiolucency formation postoperatively.
    • periapical radiolucency formation postoperatively.

    Measured: 12 months follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Sep 2022
  2. Study start1 Jan 2022
  3. Primary completion27 May 2023
  4. Study completion6 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
After informed consent, baseline clinical and radiographic assessment will be obtained and recorded in patient examination sheet. Participants who met the inclusion criteria were randomly allocated to two groups (n = 26/group, N = 52 in total) according to the capping martials using the envelope randomization method. All patients were recalled and their treated molars were evaluated clinically and radiographically at 3months, 6months, 9months ,12months follow up periods. 2 study groups according to capping material that will be used (Dycal or MTA) and each group will be divided to 2 subgroups according to site of exposure axial or pulpal
Masking
Single blind
Who is masked
Participant
Enrolment
52 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05530954
Sponsor's protocol ID
DPC in primary molars
Status last verified
Sep 2023
First submitted
3 Sep 2022
Last updated
26 Sep 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Caicedo R, Abbott PV, Alongi DJ, Alarcon MY. Clinical, radiographic and histological analysis of the effects of mineral trioxide aggregate used in direct pulp capping and pulpotomies of primary teeth. Aust Dent J. 2006 Dec;51(4):297-305. doi: 10.1111/j.1834-7819.2006.tb00447.x.

    PubMed 17256303
  • Faraco IM Jr, Holland R. Response of the pulp of dogs to capping with mineral trioxide aggregate or a calcium hydroxide cement. Dent Traumatol. 2001 Aug;17(4):163-6. doi: 10.1034/j.1600-9657.2001.170405.x.

    PubMed 11585142
  • de Lourdes Rodrigues Accorinte M, Reis A, Dourado Loguercio A, Cavalcanti de Araujo V, Muench A. Influence of rubber dam isolation on human pulp responses after capping with calcium hydroxide and an adhesive system. Quintessence Int. 2006 Mar;37(3):205-12.

    PubMed 16536148

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Mineral trioxide aggregate (MTA) and Hard setting Calcium Hydroxide (Dycal) in people with Direct Pulp Capping, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

clinical success of direct pulp capping treatment after 3 months follow up (time frame: 3 months). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05530954, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Sep 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in